{
    "2018-07-13": [
        [
            {
                "time": "",
                "original_text": "爱爾眼科2018年半年度业绩预增35%—45%",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "业绩预增",
                        "2018年半年度"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "爱尔眼科：预计上半年盈利同比增35%-45%",
                "features": {
                    "keywords": [
                        "爱尔眼科",
                        "盈利",
                        "同比增"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "半年报高增长确定 爱尔眼科市值再创新高",
                "features": {
                    "keywords": [
                        "半年报",
                        "高增长",
                        "市值",
                        "新高"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "眼科"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "精品投行如何为医疗创业续命？ | 专访浩悦资本李逸石",
                "features": {
                    "keywords": [
                        "精品投行",
                        "医疗创业",
                        "浩悦资本",
                        "李逸石"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "投资"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药行业2018中报前瞻：行业景气度底部回升 结构性行情有望延续",
                "features": {
                    "keywords": [
                        "医药行业",
                        "2018中报",
                        "景气度",
                        "结构性行情"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}